Dissecting the effects of AML1-ETO on haematopoietic differentiation and self-renewal and determining how these effects contribute to the final malignant phenotype remain a goal of leukaemia researchers (Lam and Zhang, 2012). This evidence concerns the gene RUNX1 and leukemia.